Minimal Access Surgery and General Surgery, Max Hospital, Gurugram, Haryana, India, 122001.
Paras Hospital, Gurgaon, Haryana, India.
J Wound Care. 2023 Mar 1;32(Sup3):S4-S8. doi: 10.12968/jowc.2023.32.Sup3.S4.
Surgical site infections (SSIs) are treated using topical antiseptics and systemic antibiotics, but some cases are unresponsive to such regimens. This case study reports the effective healing of an SSI by a chitosan wound dressing (MaxioCel; Axio Biosolutions Private Limited, India) in a 63-year-old female patient. The patient presented with an infected, hard-to-heal wound in the abdominal region, developed after a hernia surgery, and was initially treated with standard procedures. However, due to the continuous progression of infection, a highly absorbent, bioactive microfibre dressing was selected for the treatment and was continued for two months with alternate-day dressing changes. After 60 days of treatment, wound healing was observed, along with remission from the infection, as well as reduction in exudate level and pain. The use of chitosan wound dressing in management of hard-to-heal infected wounds provides efficient remission of SSI and a faster healing rate.
手术部位感染（SSI）采用局部抗菌剂和全身抗生素治疗，但有些病例对这些方案没有反应。本病例研究报告了在一名 63 岁女性患者中，壳聚糖创面敷料（MaxioCel；Axio Biosolutions Private Limited，印度）有效治愈 SSI 的情况。该患者在疝气手术后出现腹部感染、难以愈合的伤口，最初采用标准程序进行治疗。然而，由于感染持续进展，选择了一种高吸水性、生物活性的微纤维敷料进行治疗，并持续两个月，隔天更换敷料。经过 60 天的治疗，观察到伤口愈合，感染得到缓解，渗出物水平和疼痛减轻。在治疗难以愈合的感染性伤口时使用壳聚糖创面敷料可有效缓解 SSI 并加快愈合速度。
